Resistant starch
Overview
Resistant starch is starch that escapes digestion in the small intestine and can reach the colon. The class includes several forms. RS2 is granular starch, and RS3 is retrograded starch. A result for one form and one protocol stays there. Cooled potato or pasta in a kitchen is not automatically the preparation used in a paper.
In aged female mice, a high-fat diet plus 20% type 2 resistant starch for sixteen weeks lowered serum and faecal lipopolysaccharide and increased colonic mucin [1]. A short human intervention with resistant potato starch raised faecal butyrate in a context that varied with the microbiota [2]. In vitro, RS2 and RS3 were substrates for specialist degradation, and adding Ruminococcus bromii increased RS3 fermentation in one donor’s faecal community [3]. None of these is a general human dose, RS4 equivalence, or a clinical benefit [1,2,3].
Dietary Origin
Some cooked-and-cooled starchy foods contain more resistant starch than the hot food. That is a food-matrix fact. The mouse result used 20% type 2 resistant starch added to a high-fat diet [1]. The human butyrate result used a resistant potato starch preparation [2]. The culture result used defined RS2 and RS3 substrates [3]. No food page is linked, because a home-cooled starch is not those exposures.
Research Spotlights & Evidence Checks
Recipes
Foods
Biological Regulatory Systems
| Biological Regulatory System | Evidence-qualified relationship | Evidence |
|---|---|---|
| Gut-Brain Axis & Enteric Nervous System (BRS5) | Type 2 resistant starch in aged mice is mapped to LPS containment. Resistant potato starch is mapped to SCFA production. RS2/RS3 cultures are mapped to microbial competitive selection. | [1,2,3] |
References
[1] Zhang et al. (2020). Dietary type 2 resistant starch improves systemic inflammation and intestinal permeability by modulating microbiota and metabolites in aged mice on high-fat diet. Sixteen weeks of 20% type 2 resistant starch in aged female mice on a high-fat diet lowered serum and faecal lipopolysaccharide and increased colonic mucin. Not a human dose and not equivalence to cooled staple foods.
[2] Baxter et al. (2019). Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. Resistant potato starch was associated with increased faecal butyrate in a short human intervention. Responses vary with microbial context. Faecal concentration is not production flux, brain delivery, or clinical benefit.
[3] Ze et al. (2012). Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. RS2 and RS3 were substrates for specialist degradation. Adding R. bromii enhanced RS3 fermentation in one donor’s faecal community in vitro. Not oral probiotic efficacy and not RS4 equivalence.
BRS matrix — individual KC inputs
| BRS / PM | Relationship | Biological role and limitation |
|---|---|---|
| BRS5 · BRS5-FM1-PM1 BRS5(KC1) | Supported upstream supply | Resistant starch supplies colonic microbes whose fermentation products contribute upstream to epithelial barrier biology. Limitation: Response varies with starch type, preparation, dose and microbiota. Faecal short-chain fatty acids do not measure epithelial delivery or establish human tight-junction improvement; resistant potato starch results do not establish effects for every RS2 or RS3 preparation. Sobh et al. (2022) [13] |